Goldenwell Biotech (GWLL) Stock Price

Goldenwell Biotech Price

NYSE·CLOSED
0.65
​
Market closed

Revenue at Goldenwell Biotech has contracted by 75.8% per year over the past 4 years to 55.00 USD. Goldenwell Biotech's net margin stands at -539,038.2%, down from -732.6% several years earlier.

Goldenwell Biotech stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Goldenwell Biotech business model & stock analysis

Goldenwell Biotech, Inc. is a development stage company. The company is headquartered in Twinsburg, Ohio. The company went IPO on 2021-12-07. The firm is primarily engaged in research and development, production and sales of health cares and supplement products. The firm is offering its products under two categories: Polypeptide Freeze-dried Powder and Solid Tablets Products. The Company’s products are JI MAI-Bovine Cardiac Vascular Active Peptide, Double Proline AG- three-dimensional (3D) Active Collagen Peptide, Cartilage Peptide-Type II collagen peptide and Sugar Master. Bovine cardiac vascular active peptide is a protein peptide of vascular homology (amino acid type and its sequence), which is made from healthy and fresh bovine cardiac vascular tissues as raw material. The sugar master product ingredients include natural herbal polypeptides, concentrated and purified natural plant extracts and organic selenium complex. Its Double Proline AG product is designed to be an easily absorbed bioactive collagen.

Frequently asked questions about Goldenwell Biotech

Converted at the current exchange rate, the Goldenwell Biotech share trades at 0.58 EUR (0.65 USD).

The revenue cannot currently be calculated for Goldenwell Biotech.

The profit cannot currently be calculated for Goldenwell Biotech.

The P/E ratio cannot be calculated for Goldenwell Biotech at the moment.

The P/S cannot be calculated for Goldenwell Biotech currently.

The Eulerpool Quality Score for Goldenwell Biotech is 2/10.

The ISIN of Goldenwell Biotech is US38138N1046. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Goldenwell Biotech is GWLL. The ticker symbol is used to trade Goldenwell Biotech shares on the stock exchange.

Fair ValueTerminal
0.55 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Dec 7, 2021
ISIN
US38138N1046
Cusip
38138N104
Market capitalization
64.35 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
759.53
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
119.48 %
Last updated Oct 28, 2026, 5:00 AM

Goldenwell Biotech Peer Group

Goldenwell Biotech FIGI

GWLL:US · BBG00RVG0Z39GWLL:PQ · BBG00RVG0ZV8GWLL:UV · BBG00RVG0ZW7